INVITRO ACTIVITY OF ENOXACIN - A MULTI-CENTER-STUDY

被引：1

作者：

WIEDEMANN, B

ADAM, D

BAUERNFEIND, A

BLASIUS, C

BRAVENY, I

DASCHNER, F

GRIMM, H

HAHN, H

LANGMAACK, H

LEY, F

OPFERKUCH, W

PETERS, G

ROHR, HP

RUCKDESCHEL, G

KRAEFT, H

机构：

[1] UNIV MUNICH,ANTIMIKROBIELLE THERAPIE & INFEKT IMMUNOL ABT,D-8000 MUNICH 2,FED REP GER

[2] UNIV MUNICH,MAX VONPETTENKOFER INST HYG & MED MIKROBIOL,D-8000 MUNICH 2,FED REP GER

[3] UNIV TUBINGEN,INST HYG,D-7400 TUBINGEN 1,FED REP GER

[4] TECH UNIV MUNICH,INST MED MIKROBIOL,D-8000 MUNICH 80,FED REP GER

[5] UNIV FREIBURG KLINIKUM,HYG KLIN,D-7800 FREIBURG,FED REP GER

[6] FREE UNIV BERLIN,INST MED MIKROBIOL,D-1000 BERLIN 45,FED REP GER

[7] KRANKENHAUS MOABIT,INST HYG & MED MIKROBIOL,D-1000 BERLIN 12,FED REP GER

[8] INST MED MIKROBIOL & IMMUNOL,D-7500 KARLSRUHE 1,FED REP GER

[9] RUHR UNIV BOCHUM,INST MED MIKROBIOL,D-4630 BOCHUM 1,FED REP GER

[10] UNIV COLOGNE,INST HYG,D-5000 COLOGNE 41,FED REP GER

[11] STAATLICHES INST HYG & INFEKT KRANKHEITEN,D-6600 SAARBRUCKEN 1,FED REP GER

[12] UNIV MUNICH,KLINIKUM GROSSHADERN,MED MIKROBIOL,D-8000 MUNICH 70,FED REP GER

[13] PARKE DAVIS & CO,D-7800 FREIBURG,FED REP GER

来源：

INFECTION | 1989年 / 17卷

关键词：

D O I：

10.1007/BF01643625

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：S3 / S5

页数：3

共 50 条

[41] RATIONALE FOR THE INVITRO STUDY OF NEUROMUSCULAR ACTIVITY
STUREK, M
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1987, 19 (05): : S121 - S129
[42] STUDY ANTIBACTERIAL ACTIVITY OF NIFUROXAZIDE INVITRO
BUISSON, Y
LANG, T
SALIOU, P
MEDECINE ET MALADIES INFECTIEUSES, 1988, 18 (02): : 64 - 69
[43] CEFTRIAXONE - A 3 CENTER COMPARATIVE INVITRO SUSCEPTIBILITY STUDY
EMMERSON, AM
LAMPORT, PA
REEVES, DS
BYWATER, MJ
HOLT, HA
WISE, R
ANDREWS, J
HALL, MJ
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1985, 4 (02) : 142 - 144
[44] INVITRO ACTIVITIES OF CEFAMANDOLE AND CEPHALOTHIN AGAINST 1,881 CLINICAL ISOLATES - MULTI-CENTER STUDY
BARRY, AL
SCHOENKNECT, FD
SHADOMY, S
SHERRIS, JC
THORNSBERRY, C
WASHINGTON, JA
KAMMER, RB
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1979, 72 (05) : 858 - 860
[45] Decitabine Activity in Myelodysplastic Syndromes. International Cooperative Multi-Center Study
Iastrebner, Marcelo
Jang, Jun Ho
Nucifora, Elsa
Kim, Kihyun
Sackmann, Federico
Kim, Dong Hwan
Orlando, Sergio
Jung, Chu Won
Basquiera, Ana
Bengio, Raquel
Quiroga, Luis
Klein, Graciela
Garcia, Juan
Arbelbide, Jorge
Pavlovsky, Astrid
Virginia Prates, Maria
BLOOD, 2009, 114 (22) : 1463 - 1463
[46] Morphine affects brain activity and volumes in preterms: An observational multi-center study
Tataranno, M. L.
Gui, L.
Hellstrom-Westas, L.
Toet, M.
Groenendaal, F.
Claessens, N. H. P.
Schuurmans, J.
Fellman, V
Savman, K.
de Vries, L. S.
Huppi, P.
Benders, M. J. N. L.
EARLY HUMAN DEVELOPMENT, 2020, 144
[47] Pharmaceutical salts/cocrystals of enoxacin with dicarboxylic acids: Enhancing in vitro antibacterial activity of enoxacin by improving the solubility and permeability
Liu, Lixin
Zou, Dongyu
Zhang, Yunan
Zhang, Qiang
Feng, Yanru
Guo, Yingxue
Liu, Yingli
Zhang, Xuesong
Cheng, Guangdong
Wang, Chaoxing
Zhang, Yunjie
Zhang, Lei
Wu, Lili
Chang, Liang
Su, Xin
Duan, Yu
Zhang, Yanfei
Liu, Moqi
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 154 : 62 - 73
[48] AFIBRINOGENEMIA EXPERIENCE MULTI CENTER STUDY
Tuncel, D. A.
Gok, V.
Pekpak, E.
Tokgoz, H.
Acipayam, C.
Yilmaz, E.
Oren, A. C.
Ozcan, A.
Karakukcu, M.
Unal, E.
Akbayram, S.
Caliskan, U.
Patiroglu, T.
HAEMOPHILIA, 2020, 26 : 148 - 149
[49] COMPARATIVE INVITRO ACTIVITIES OF PEFLOXACIN, OFLOXACIN, ENOXACIN AND CIPROFLOXACIN AGAINST 256 CLINICAL ISOLATES
ARPI, M
GAHRNHANSEN, B
SOGAARD, P
BENTZON, MW
ACTA PATHOLOGICA MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA SECTION B-MICROBIOLOGY, 1987, 95 (02): : 141 - 146
[50] INVITRO SUSCEPTIBILITY OF AEROBIC GRAM-NEGATIVE BLOOD CULTURE ISOLATES TO OXOLINIC ACID, NORFLOXACIN, CIPROFLOXACIN, ENOXACIN, PEFLOXACIN, OFLOXACIN AND OXO-ENOXACIN
VANDERAUWERA, P
INFECTION, 1986, 14 (03) : 142 - 144

← 1 2 3 4 5 →